Advertisement
Advertisement

ZVSA

ZVSA logo

ZyVersa Therapeutics, Inc. Common Stock

1.22
USD
-0.03
-2.46%
Feb 21, 15:51 UTC -5
Closed
exchange

After-Market

1.2

-0.02
-1.64%

ZyVersa Therapeutics, Inc. Common Stock Profile

About

ZyVersa Therapeutics Inc. is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates which address high unmet medical needs in the areas of renal and inflammatory diseases. The company's development pipeline includes phase 2a ready VAR 200 and IC 100. ZyVersa Therapeutics Inc., formerly known as Larkspur Health Acquisition Corp., is based in WESTON, Fla.

Info & Links

CEO

Stephen C. Glover

Headquarters

2200 N. COMMERCE PARKWAY, SUITE 208
WESTON, FL 33326, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.zyversa.com

Auditor

Marcum LLP

Share holders

95

Employees

7

ZyVersa Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.81M

Enterprise Value

2.69M

Enterprise Value/EBITDA(ttm)

-0.12

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-224.85%

Return on Invested Capital(ttm)

-211.85%

Return on Assets(ttm)

-103.22%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-21.78M

Net Income Available to Common(ttm)

-21.33M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.47

52-Week Change

-80.00%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

2.34M

Dividend Yield

0.00%

Float4

2.34M

% Held by Insiders

0.26%

% Held by Institutions

3.91%

Balance Sheet

Total Cash(mrq)

122.90K

Total Cash Per Share(mrq)

0.05

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.03%

Quick Ratio(mrq)

0.03%

Book Value Per Share(mrq)

6.54

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.41

Free Cash Flow(ytd)

-6.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement